Remove 2023 Remove Communication Remove Documentation
article thumbnail

FDA Publishes Its Draft Strategy Document on Innovative Manufacturing Technologies

The FDA Law Blog

FDA-2024-N-3945 ] announcing the publication of a draft strategy document, for public comment, outlining specific actions FDA plans to take to facilitate the use of innovative manufacturing technologies. It was at this workshop that the agency committed to issuing a draft strategy document, for public comment.

article thumbnail

Pharmacy Star Ratings Changes Coming in 2023

Digital Pharmacist

b) Marketing and Communications Oversight. Medicare beneficiaries will be secured by CMS’s finalization of revisions to marketing and communications regulations that will guarantee they get accurate and understandable information about their coverage. Remind patient regarding preventive services and other communications.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

State of Well-Being 2023-2024

The Happy PharmD

Well, now’s the perfect time to dive into a discussion with me about the latest insights from the 2023 report by the Well-Being Index. Watch this discussion on YouTube: 2023 Well-Being Report: Are Pharmacist Stress Levels Being Downplayed? The post State of Well-Being 2023-2024 appeared first on The Happy PharmD.

article thumbnail

Participate in the Measure Development Process in 2023

PQA

In 2023, PQA’s COPD Treatment Ratio (CTR) TEP will conclude following its launch in 2022. PQA will launch two additional TEPs in 2023. Self-nominations for these TEPs will be communicated to PQA members in the second or third quarter of 2023, and we encourage interested PQA members to submit a self-nomination for consideration.

article thumbnail

5 Tips For Incoming PGY2 Pharmacy Residents

IDStewardship

BCPS, BCIDP Article posted: 12 May 2023 The ASHP pharmacy residency match phases 1 and 2 have come to a close. Review your schedule, elective options, and documentation responsibilities We have to start with the basics in order to adequately orient to future expectations. Knowing how the RPD communicates is important.

article thumbnail

New regulatory relief to benefit Europe’s pharma SMEs

European Pharmaceutical Review

As small and medium-sized enterprises (SMEs) often face unfair competition when doing business in Europe, through the (SME) Relief Communication, the European Commission (EC) has proposed new measures to provide short-term relief, boost long-term competitiveness, and improve equality in the business environment across the Single Market in Europe.

article thumbnail

How ready are you? Preparing for the impact of EU GMP Annex 1 on primary packaging

European Pharmaceutical Review

While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively reset the benchmark for quality standards across the globe on 25 August 2023.